National health care costs of peripheral arterial disease in the Medicare population.
about
Critical Limb Ischemia: Current Trends and Future DirectionsPeripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomesMyoglobin overexpression inhibits reperfusion in the ischemic mouse hindlimb through impaired angiogenesis but not arteriogenesis.Invasively-treated incidence of lower extremity peripheral arterial disease and associated factors in Taiwan: 2000-2011 nationwide hospitalized data analysisEfficacy of brief behavioral counselling by allied health professionals to promote physical activity in people with peripheral arterial disease (BIPP): study protocol for a multi-center randomized controlled trial.Infrainguinal open reconstruction: a review of surgical considerations and expected outcomes.Impaired vascular endothelial growth factor A and inflammation in patients with peripheral artery disease.Greater endothelial apoptosis and oxidative stress in patients with peripheral artery diseaseCritical limb ischemian-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network.Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional study.Gender and racial differences in endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea: a National Health Insurance Database Study.Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs.Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trialThe FReedom from Ischemic Events-New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery disease.Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.A review of the pathophysiology and potential biomarkers for peripheral artery disease.Roles for specialty societies and vascular surgeons in accountable care organizations.Risk of Peripheral Artery Occlusive Disease in Patients with Vertigo, Tinnitus, or Sudden Deafness: A Secondary Case-Control Analysis of a Nationwide, Population-Based Health Claims DatabaseUltrasound assessment of the caliber of the arteries in the lower extremities in healthy persons - the dependency on age, sex and morphological parameters of the subjects.Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease.Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.Effect of cognitive status on exercise performance and quality of life in patients with symptomatic peripheral artery diseaseDiagnosis and management of peripheral artery disease in women.INFLUENCE OF DIABETES ON AMBULATION AND INFLAMMATION IN MEN AND WOMEN WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASECost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.Influence of peripheral artery disease and statin therapy on apolipoprotein profiles.Association between gait characteristics and endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.Claudication: exercise vs endoluminal revascularization (CLEVER) study update.The burden of peripheral artery disease and the role of antiplatelet therapy.Predictors of Improved Walking after a Supervised Walking Exercise Program in Men and Women with Peripheral Artery Disease.Multimodality imaging approach for serial assessment of regional changes in lower extremity arteriogenesis and tissue perfusion in a porcine model of peripheral arterial disease.Inflammatory Bowel Disease Increases the Risk of Peripheral Arterial Disease: A Nationwide Cohort Study.Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions.Therapeutic strategies for cell-based neovascularization in critical limb ischemiaDiabetic women are poor responders to exercise rehabilitation in the treatment of claudication.
P2860
Q26767021-7EECC3EA-0021-4D1B-AB80-E733ADA26F03Q26799591-D156A116-C2C0-4E52-9F5C-A041B8BB2AE4Q30457043-71ECF9B2-6398-4ED7-85AC-66928411EF91Q30704175-6E91D0C1-0248-4540-AB58-BC91BB9B416AQ30828214-96DAA662-FE1C-485C-BC5D-71CC1AE3E2CDQ33674067-9AF6F650-CDB2-4920-8605-45988A34D346Q33707341-CCECE17F-7A79-4B5A-BDCA-8D3B291BEA29Q33745594-1B6E6B34-44FB-4401-A6F9-811EAA269A36Q33814176-A91DFE6E-3A93-4188-953C-0F965FA07308Q33819705-3833C9A9-1E56-4E19-B789-397D1AB26080Q33901024-701AADE4-5316-4A2A-96F2-09DA8CFE04B2Q33914132-164BCB00-DBFC-4189-8FC8-CD0F7D30D0E2Q34288235-7D5B787B-7C21-4B48-85DD-1F0F9E8290B2Q34352362-064F7905-F9A3-4C17-9052-C07F1D9380C9Q34546377-C91B5973-D77D-4DE3-9E4A-F951342411C7Q34627929-35689820-7CC1-4397-80D8-77AE291267C2Q35070663-DCF8538C-4C30-42DA-A26D-43887232B35EQ35071874-BD44C65F-1B12-4416-BD7F-D6B0CC0096DFQ35114977-7A590AD0-8C38-48F1-A9AF-1E04946DF6AEQ35540524-6D345A9C-8F0A-475A-9872-4594D09D53A2Q35723731-C11B6957-9070-412E-93BB-DDDE1F60505FQ35920050-190AF524-EBF0-42AE-9A9F-D15517EE8225Q36134116-0B0E7EEE-C934-43C0-8651-F7DF48E16298Q36154283-CBD2D192-FFE8-451B-8238-FE91C391116BQ36307762-A55462AD-A3F0-4815-8718-95A8536687CFQ36330155-E6DFC946-352A-447C-B6CB-5F6CFAC9C4AEQ36421157-B27E5423-55B1-491D-9B37-ADD0FBD7410FQ36493454-097B0E88-5C49-46B7-815C-24BC8DE3FAE4Q36514230-68D11199-1499-408B-BAAF-5E2E4316ABF5Q37015495-C4FC7FC9-CBC1-427A-8C47-48E588D7B64FQ37206137-58F04229-9B64-44DD-8861-99A39A0F8385Q37219653-C7B86556-F92C-4BBE-A6EB-CCF1557E3B48Q37368953-D3C95D02-874E-43B4-8A8B-B60616B54FFBQ37566082-5E6BEDFA-1AA4-4C30-B2FC-9F1B24CE244CQ37571995-19D8DBB6-157C-4A04-84A1-798B290D9360Q37594559-6160F0CA-7090-492A-990D-1249F751922AQ37624235-DDE3AFDD-2000-44D8-AB41-40D630AC67AAQ37659682-314912BF-C07A-484D-93BC-0F67CDC9A81AQ37663453-B62207CD-2AE5-403B-A625-0964464DB51CQ37666042-3456E88A-2412-4B3A-8DD5-0C5AEAA2B141
P2860
National health care costs of peripheral arterial disease in the Medicare population.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
National health care costs of peripheral arterial disease in the Medicare population.
@en
type
label
National health care costs of peripheral arterial disease in the Medicare population.
@en
prefLabel
National health care costs of peripheral arterial disease in the Medicare population.
@en
P2093
P2860
P356
P1433
P1476
National health care costs of peripheral arterial disease in the Medicare population.
@en
P2093
Alan T Hirsch
Beth A Virnig
Lacey Hartman
Robert J Town
P2860
P304
P356
10.1177/1358863X08089277
P577
2008-08-01T00:00:00Z